Search Results - "Salako, Michael A"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker by Flak, Magdalena B, Connell, Claire M, Chelala, Claude, Archibald, Kyra, Salako, Michael A, Pirlo, Katrina J, Lockley, Michelle, Wheatley, Sally P, Balkwill, Frances R, McNeish, Iain A

    Published in Molecular cancer (03-07-2010)
    “…The oncolytic adenovirus dl922-947 replicates selectively within and lyses cells with a dysregulated Rb pathway, a finding seen in > 90% human cancers…”
    Get full text
    Journal Article
  3. 3

    Coxsackievirus Protein 2BC Blocks Host Cell Apoptosis by Inhibiting Caspase-3 by Salako, Michael A., Carter, Michael J., Kass, George E.N.

    Published in The Journal of biological chemistry (16-06-2006)
    “…Virus infection may induce host cell death by apoptosis, but some DNA viruses are capable of preventing this process. RNA viruses were thought not to display…”
    Get full text
    Journal Article
  4. 4

    Inhibition of the Inflammatory Cytokine TNF-α Increases Adenovirus Activity in Ovarian Cancer via Modulation of cIAP1/2 Expression by Salako, Michael A, Kulbe, Hagen, Ingemarsdotter, Carin K, Pirlo, Katrina J, Williams, Sarah L, Lockley, Michelle, Balkwill, Frances R, McNeish, Iain A

    Published in Molecular therapy (01-03-2011)
    “…Oncolytic adenoviruses show promise as a cancer treatment. However, they generate acute inflammatory responses with production of cytokines, including tumor…”
    Get full text
    Journal Article
  5. 5

    Human herpesvirus 1 protein US3 induces an inhibition of mitochondrial electron transport by Derakhshan, Mohammad, Willcocks, Margaret M, Salako, Michael A, Kass, George E. N, Carter, Michael J

    Published in Journal of general virology (01-08-2006)
    “…School of Biomedical and Molecular Sciences, University of Surrey, Guildford GU2 7XH, UK Correspondence Michael J. Carter m.carter{at}surrey.ac.uk Previous…”
    Get full text
    Journal Article
  6. 6

    Abstract 591: Host cell DNA damage and inflammation responses determine oncolytic adenovirus efficacy in ovarian cancer by Salako, Michael A., Connell, Claire M., Shibata, Atsushi, Graupner, Vilma, Lockley, Michelle, Balkwill, Frances R., McNeish, Iain A.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract Introduction. Oncolytic adenoviruses show promise as a cancer treatment, by replicating selectively within malignant cells. Viral replication requires…”
    Get full text
    Journal Article
  7. 7

    Inhibition of the Inflammatory Cytokine TNF-[alpha] Increases Adenovirus Activity in Ovarian Cancer via Modulation of cIAP1/2 Expression by Salako, Michael A, Kulbe, Hagen, Ingemarsdotter, Carin K, Pirlo, Katrina J, Williams, Sarah L, Lockley, Michelle, Balkwill, Frances R, Mcneish, Iain A

    Published in Molecular therapy (01-03-2011)
    “…Oncolytic adenoviruses show promise as a cancer treatment. However, they generate acute inflammatory responses with production of cytokines, including tumor…”
    Get full text
    Journal Article
  8. 8

    Human herpesvirus 1 protein U sub(S)3 induces an inhibition of mitochondrial electron transport by Derakhshan, Mohammad, Willcocks, Margaret M, Salako, Michael A, Kass, George EN, Carter, Michael J

    Published in Journal of general virology (01-08-2006)
    “…Previous studies have identified virus proteins that traffic to mitochondria and may affect mitochondrial function. Here, it is reported that Human herpesvirus…”
    Get full text
    Journal Article